CVE-2022-30277 in Synapsys
Summary
by MITRE • 06/02/2022
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Analysis
by VulDB Data Team • 06/06/2022
The BD Synapsys™ platform version 4.20, 4.20 SR1, and 4.30 contains a critical session management vulnerability that directly impacts the security posture of healthcare organizations handling sensitive patient data. This vulnerability falls under the CWE-613 weakness category, which specifically addresses insufficient session expiration mechanisms that allow attackers to maintain unauthorized access to systems beyond the normal session timeout periods. The flaw represents a fundamental failure in the application's authentication and authorization framework, creating persistent access vectors that can be exploited by threat actors to gain prolonged unauthorized access to critical healthcare information systems.
The technical implementation of this vulnerability stems from inadequate session lifecycle management within the BD Synapsys™ application. When users authenticate to the system, the platform should enforce strict session expiration policies that automatically terminate user sessions after a predetermined period of inactivity or upon explicit logout. However, the affected versions fail to properly enforce these session expiration controls, allowing authenticated sessions to remain active indefinitely or for extended periods beyond normal operational requirements. This weakness creates a persistent access window that threat actors can exploit through various attack vectors including session hijacking, credential theft, or exploitation of compromised user accounts.
The operational impact of this vulnerability extends beyond simple unauthorized access to encompass the complete compromise of sensitive healthcare data repositories. The system's exposure to unauthorized access directly violates the security controls mandated by the Health Insurance Portability and Accountability Act (HIPAA) and related regulations governing the protection of electronic protected health information (ePHI). Threat actors exploiting this vulnerability can potentially access, modify, or delete protected health information (PHI) and personally identifiable information (PII) stored within the platform, creating risks of data breaches, identity theft, and regulatory compliance violations that can result in significant financial penalties and reputational damage to healthcare organizations.
This vulnerability aligns with several tactics and techniques documented in the MITRE ATT&CK framework, particularly under the credential access and persistence domains. Attackers can leverage this weakness to maintain long-term access to healthcare systems, enabling them to conduct extended surveillance operations or execute data exfiltration campaigns without detection. The vulnerability also maps to the privilege escalation and defense evasion categories, as threat actors can exploit the persistent session access to escalate privileges within the system and avoid detection mechanisms. Organizations should consider implementing additional monitoring controls to detect anomalous session behavior and establish more robust session management policies that align with industry best practices for healthcare information systems.
The remediation approach for this vulnerability requires immediate implementation of proper session expiration controls within the BD Synapsys™ platform. Organizations should work with BD to obtain and apply the appropriate security patches or updates that address the insufficient session expiration flaw. Additionally, implementing session management best practices including automatic session timeouts, secure session handling, and regular session validation checks will help mitigate the risk of exploitation. Network monitoring solutions should be configured to detect and alert on suspicious session activity patterns, while access logging should be enhanced to track session lifecycle events and identify potential abuse of the vulnerable system components. The vulnerability represents a clear violation of the principle of least privilege and demonstrates the critical importance of proper session management in healthcare environments where patient data security is paramount.